Middle East & Africa Dermatology Drugs Market Research Report: Forecast (2021-2026)

Name: Middle East & Africa Dermatology Drugs Market Research Report: Forecast (2021-2026)
Creator: MarkNtel Advisors
License: https://www.marknteladvisors.com/privacy-policy

By Drug Type (Branded, Generics), By Drug Class (Corticosteroids, Retinoid, Monoclonal Antibodies, Antibiotics Agents, Antiviral Agents, Antifungal Drugs, Antihistamines Agents, Im...munosuppressive Drugs), By Application (Psoriasis, Atopic dermatitis, Acne, Rosacea, Skin cancer, Scar, Others), By End Users (Hospitals, Cosmetic-Centers, Dermatology Clinics, Homecare, Others), By Prescription Mode (Prescription Based Drugs, OTC Drugs), By Route of Administration (Topical, Oral, Parenteral), By Distribution Channel (Direct, Retail/wholesale, Online), By Geographic Region (UAE, Saudi Arabia, Qatar, Turkey, South Africa), By Competitors (Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., Amgen Inc., AbbVie Inc., Eli Lilly and Company, Galderma S.A., GlaxoSmithKline plc, Mylan N.V.) Read more

Healthcare
Mar 2021
Pages 187
Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

Market Overview

Dermatology drugs prevent or treat various skin disorders in humans, including the daily skincare routine to maintain the skin.

According to the MarkNtel Advisors' research report, "The Middle East and Africa Dermatology Drug Market Analysis, 2021," the market is likely to grow at a CAGR of around 7% between 2021-26. The growth attributes to the rising prevalence of skin diseases & disorders and increasing awareness about skincare drugs among the population. The surging demand for skincare products among the youth is likely to spur opportunities for the dermatology drugs market in the Middle East and Africa region.

Report Coverage	Details
Study Period	Historical Data: 2016-19
	Base Year: 2020
	Forecast Period: 2021-26
CAGR (2021-2026)	7%
Countries Covered	UAE, Saudi Arabia, Qatar, Turkey, South Africa
Key Companies Profiled	Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., Amgen Inc., AbbVie Inc., Eli Lilly and Company, Galderma S.A., GlaxoSmithKline plc, Mylan N.V.
Unit Denominations	USD Million/Billion

Impact of COVID-19

Due to the outbreak of the COVID-19 pandemic, the Middle East and African dermatology drug market came to a standstill position due to the temporary closure of dermatology-clinics during the lockdown. However, the market can regain its pace in the forecast period due to lockdown relaxations by the government.

Market Segmentation

Atopic Dermatitis Accounted for the Largest Market Share

Based on application, the atopic dermatitis segment acquired the largest market share in Middle East and Africa Dermatology Drug Market in 2019. Atopic dermatitis is one of the most common kinds of eczema in which skin gets red and itchy. The growth of this segment attributes to the rising expenditure on R&D activities and campaigns to raise atopic dermatitis awareness, thereby resulting in the rise of the dermatology drug market, reveals MarkNtel Advisors in their research report, "The Middle East and Africa Dermatology Drug Market Analysis, 2021."

Middle East & Africa Dermatology Drugs Market Grow at CAGR of 7% by 2026 - MarkNtel Advisors

Generic Drugs Acquired the Highest Market Share

Based on drug type, the market classifies into branded drugs and generic drugs. Among these segments, generic drugs held the largest share in the Middle East and Africa Dermatology Drug Market in 2019. The primary factor driving the growth of these drugs is the burgeoning trend of outsourcing as a market strategy by vendors to reduce their capital. Moreover, the cost-effectiveness of generic drugs provides them with a competitive benefit over branded drugs. Thus, this segment is likely to grow substantially during 2016-26, reveals MarkNtel Advisors in their research report, "The Middle East and Africa Dermatology Drug Market Analysis, 2021."

Regional Landscape

Saudi Arabia Exhibits Fastest Growth

Saudi Arabia is amongst the fastest growing market due to swift transformations in the healthcare sector and the frequent launches of innovative drugs by market players.

Additionally, the rise in the number of partnerships and collaborations in the healthcare industry is fueling the growth of the dermatology drug market. However, high dependency on imports and frequent drug recalls by the Ministry of Health Saudi Arabia is the biggest challenge that could restrain the market growth.

Market Driver

Surging Patient Population to Support Market Growth

The rising number of patients suffering from skin infections or disorders, such as scars, acne, dermatitis, etc., is likely to spur the growth opportunities for the market in the forecast period. The increasing awareness regarding numerous dermatology products curing skin problems and the surging product portfolios contributes to the market growth.

Competitive Landscape

According to the MarkNtel Advisors, the major leading players in the Middle East and Africa Dermatology Drug Market are Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., Amgen Inc., AbbVie Inc., Eli Lilly and Company, Galderma S.A., GlaxoSmithKline plc, Mylan N.V.

Key Questions Answered in the Market Research Report:

What are the primary overall market statistics or estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of "The Middle East and Africa Dermatology Drug Market Analysis, 2021"?
What are the country-wise industry size, growth drivers, challenges, and key market trends?
What are the key innovations, technology upgrades, opportunities, regulations in the Middle East and Africa Dermatology Drug Market?
Who are the key competitors or market players, and how do they perform in the Middle East and Africa Dermatology Drug Market based on a competitive benchmarking matrix?
What are the key results derived from the market surveys conducted during the Middle East and Africa Dermatology Drug Market study?

Frequently Asked Questions

A. The historical data has been provided since 2016, while the base year is 2020, and the data forecast is up to 2026.

A. The market size/industry size or the market value is in terms of USD Million.

A. The Middle East and Africa Dermatology Drug Market are forecast to grow at a CAGR of 7% during 2021-26.

A. Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., Amgen Inc., AbbVie Inc., Eli Lilly and Company, Galderma S.A., GlaxoSmithKline plc, Mylan N.V. are few of the leading players in the Middle East and Africa Dermatology Drug Market.

A. Generic Drug is likely to attain the highest CAGR during the forecast period and maintain its significant market share.

A. Saudi Arabia continues to grow at the highest CAGR, thereby offering immense opportunities for market leaders of the Middle East and Africa Dermatology Drug Markets.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Definition
Executive Summary
Middle East & Africa Dermatology Drug Market Outlook 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Drug Type
    1. Branded
    2. Generics
  2. By Drug Class
    1. Corticosteroids
    2. Retinoid
    3. Monoclonal Antibodies
    4. Antibiotics Agents
    5. Antiviral Agents
    6. Antifungal Drugs
    7. Antihistamines Agents
    8. Immunosuppressive Drugs
  3. By Application
    1. Psoriasis
    2. Atopic dermatitis
    3. Acne
    4. Rosacea
    5. Skin cancer
    6. Scar
    7. Others
  4. By End-User
    1. Hospitals
    2. Cosmetic Centers
    3. Dermatology Clinics
    4. Homecare
    5. Others
  5. By Prescription Mode
    1. Prescription Based Drugs
    2. Over The Counter (OTC) Drugs
  6. By Route of Administration
    1. Topical
    2. Oral
    3. Parenteral
  7. By Distribution Channel
    1. Direct
    2. Retail/wholesale
    3. Online
  8. By Country
    1. UAE
    2. Saudi Arabia
    3. Qatar
    4. Turkey
    5. South Africa
    6. Others
  9. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
UAE Dermatology Drug Market Outlook 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Drug Class
  3. By Application
  4. By End-User
  5. By Prescription Mode
  6. By Distribution Channel
  7. By Route of Administration
Saudi Arabia Dermatology Drug Market Outlook 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Drug Class
  3. By Application
  4. By End-User
  5. By Prescription Mode
  6. By Distribution Channel
  7. By Route of Administration
Qatar Dermatology Drug Market Outlook 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Drug Class
  3. By Application
  4. By End-User
  5. By Prescription Mode
  6. By Distribution Channel
  7. By Route of Administration
Turkey Dermatology Drug Market Outlook 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Drug Class
  3. By Application
  4. By End-User
  5. By Prescription Mode
  6. By Distribution Channel
  7. By Route of Administration
South Africa Dermatology Drug Market Outlook 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Drug Class
  3. By Application
  4. By End-User
  5. By Prescription Mode
  6. By Distribution Channel
  7. By Route of Administration
Middle East & Africa Dermatology Drug Market Regulations
Middle East & Africa Dermatology Drug Market Trends & Insights
Middle East & Africa Dermatology Drug Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Middle East & Africa Dermatology Drug Market Hotspot and Opportunities
Middle East & Africa Dermatology Drug Market Key Strategic Imperatives for Success and Growth
Competition Outlook
1. Competition Matrix
  1. Target Markets
  2. Target End Users
  3. Research & Development
  4. Strategic Alliances
  5. Strategic Initiatives
2. Company Profiles (Business Description, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Bausch Health Companies Inc.
  2. Novartis AG
  3. Pfizer Inc.
  4. Bristol-Myers Squibb Company
  5. Johnson & Johnson
  6. Merck & Co. Inc.
  7. Amgen Inc.
  8. AbbVie Inc.
  9. Eli Lilly and Company
  10. Galderma S.A.
  11. GlaxoSmithKline plc
  12. Mylan N.V.
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying

Talk to our Consultant

Request Customization

Global / Regional Reports

Report Walkthrough

Related Reports

Customization Offered

Our Clients

Client Testimonial

The decision to outsource a significant portion of clinical trials to India was initially met with skepticism, but with the assistance of MarkNtel, the process proved to be highly successful. MarkNtel likely played a crucial role in facilitating and managing the outsourcing venture, providing expertise, guidance, and possibly acting as a liaison between your company and the outsourced partners in India.

Head of Planning - A FMCG Company

We were very impressed with the thoroughness of the research, professionalism, calibre, detail, and robustness of the work, as well as with how MarkNtel went above and beyond to encourage us to consider our strategies and the originality of the analytical framework used to support them, to name just a few facets of the engagement. We were pleasantly surprised by the analysis's results and recommendations, which well above our initial projections.

Business head - Pharmaceutical Giant

We have cross-validated your information with our sales and marketing guys on the field and your findings represent the true picture. This is the first time a research firm has not shown us disappointment. I like the way your team keeps sharing the new developments or changes in the industry even after the completion of our mutual contract. I really appreciate your client caring attitude. Keep going!

Country Head - (A leading Latin American Energy Conglomerate)

Head of Planning - A FMCG Company

Business head - Pharmaceutical Giant

Country Head - (A leading Latin American Energy Conglomerate)

Middle East & Africa Dermatology Drugs Market Research Report: Forecast (2021-2026)

Middle East & Africa Dermatology Drugs Market Statistics and Insights, 2025